Comparison Overview

Dr Consulta

VS

Vaccine Ambassadors

Dr Consulta

None
Last Update: 2025-11-28
Between 750 and 799

¿Eres médico? ¡AFILIATE! Somos una Red de Servicios de Salud a Nivel Nacional. A través de nuestro portal web y medios sociales, tus potenciales nuevos pacientes te podrán localizar, te brindamos un respaldo integral para que tu negocio de salud crezca en tu sector. Ahora cuentas con un servicio que te permite sistematizar los procesos de atención y registro de tus pacientes con una herramienta completa, eficiente y ágil para la atención oportuna de tus pacientes.

NAICS: 92312
NAICS Definition: Administration of Public Health Programs
Employees: 7
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Vaccine Ambassadors

undefined, Chapel Hill, North Carolina, undefined, US
Last Update: 2025-11-28

Through a joint initiative, Facilitating Equitable Access to Vaccines in the Americas, with our partners at the Pan American Health Organization, Vaccine Ambassadors funds the purchase and shipping of high-quality vaccines for children and families residing in Latin America and the Caribbean. In order to maximize impact, vaccine selection is based on priority needs identified by in-country public health experts. In addition to addressing routine immunizations, Vaccine Ambassadors provides emergency vaccines following natural disasters and during humanitarian crises. To date we have provided nearly 1 million vaccines covering 12 different diseases. Pandemic-related disruptions and the diversion of resources from routine immunization programs have left millions of children at risk for many life-threatenting vaccine-preventable diseases worldwide. Vaccine Ambassadors leverages the goodwill of individuals and organizations to become partners in this important global health initiative. Together we can make a lasting impact that is tangible, affordable, and profoundly meaningful.

NAICS: 923
NAICS Definition:
Employees: 1
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/dr-consulta.jpeg
Dr Consulta
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/vaccine-ambassadors.jpeg
Vaccine Ambassadors
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Dr Consulta
100%
Compliance Rate
0/4 Standards Verified
Vaccine Ambassadors
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Public Health Industry Average (This Year)

No incidents recorded for Dr Consulta in 2025.

Incidents vs Public Health Industry Average (This Year)

No incidents recorded for Vaccine Ambassadors in 2025.

Incident History — Dr Consulta (X = Date, Y = Severity)

Dr Consulta cyber incidents detection timeline including parent company and subsidiaries

Incident History — Vaccine Ambassadors (X = Date, Y = Severity)

Vaccine Ambassadors cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/dr-consulta.jpeg
Dr Consulta
Incidents

No Incident

https://images.rankiteo.com/companyimages/vaccine-ambassadors.jpeg
Vaccine Ambassadors
Incidents

No Incident

FAQ

Both Dr Consulta company and Vaccine Ambassadors company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

Historically, Vaccine Ambassadors company has disclosed a higher number of cyber incidents compared to Dr Consulta company.

In the current year, Vaccine Ambassadors company and Dr Consulta company have not reported any cyber incidents.

Neither Vaccine Ambassadors company nor Dr Consulta company has reported experiencing a ransomware attack publicly.

Neither Vaccine Ambassadors company nor Dr Consulta company has reported experiencing a data breach publicly.

Neither Vaccine Ambassadors company nor Dr Consulta company has reported experiencing targeted cyberattacks publicly.

Neither Dr Consulta company nor Vaccine Ambassadors company has reported experiencing or disclosing vulnerabilities publicly.

Neither Dr Consulta nor Vaccine Ambassadors holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Dr Consulta company nor Vaccine Ambassadors company has publicly disclosed detailed information about the number of their subsidiaries.

Dr Consulta company employs more people globally than Vaccine Ambassadors company, reflecting its scale as a Public Health.

Neither Dr Consulta nor Vaccine Ambassadors holds SOC 2 Type 1 certification.

Neither Dr Consulta nor Vaccine Ambassadors holds SOC 2 Type 2 certification.

Neither Dr Consulta nor Vaccine Ambassadors holds ISO 27001 certification.

Neither Dr Consulta nor Vaccine Ambassadors holds PCI DSS certification.

Neither Dr Consulta nor Vaccine Ambassadors holds HIPAA certification.

Neither Dr Consulta nor Vaccine Ambassadors holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.